Does QSBS apply to a medical practice? And the 2026 Opportunity Zone timing trap

Why does everyone ask about QSBS?

Qualified small business stock, or QSBS, is a federal rule under Section 1202 that lets an investor exclude some or all of the gain on stock in a small C corporation held for several years. Founders and early employees of technology companies use it, and the 2025 tax law made it more generous. So when a physician hears that a $10 million gain might be tax-free, the question is natural. For a medical practice, the answer is short and it is no.

What does Section 1202 say after the 2025 tax law?

The One Big Beautiful Bill Act (Public Law 119-21) changed the rules for stock issued after July 4, 2025. Under the new tiered schedule, a holder can exclude 50 percent of the gain after holding the stock 3 years, 75 percent after 4 years, and 100 percent after 5 years. The cap on excluded gain per company rose to $15 million. The company's gross assets must be $75 million or less at the time the stock is issued. Stock issued on or before July 4, 2025 keeps the older rules, which required a 5-year hold and had lower caps.

Those are attractive terms. They are also beside the point for a practice sale, because of one paragraph in the statute.

Why does my practice never qualify?

Section 1202(e)(3) lists the businesses that cannot be qualified small businesses. The list includes any trade or business involving the performance of services in the field of health. It also names law, engineering, accounting, actuarial science, performing arts, consulting, athletics, financial services, and brokerage. A medical or dental professional corporation is a health services business by definition. It does not matter whether it is taxed as a C corporation or an S corporation, how long you have owned it, or how small it is. Stock in your PC is never QSBS.

A related rule, Section 1045, lets an investor roll gain from QSBS into new QSBS without tax. Because your PC stock is not QSBS to begin with, Section 1045 is not available on the practice sale either.

Could the MSO holding company stock be QSBS?

This is the one place the question has some life, and the answer is that nobody knows yet. In most private equity deals your rollover is not stock in your PC. It is an interest in the management company or a holding company above it. The management company does not practice medicine. It provides billing, staffing, real estate, and administration to practices. If that holding company is a C corporation with gross assets under $75 million when your stock is issued, some advisors argue the stock could be QSBS.

Others disagree. The management company's entire business exists to serve health services businesses, and its revenue comes from a management fee charged to medical practices. The IRS has not ruled on whether that is a health services business under Section 1202(e)(3). Most platform holding companies are also partnerships or LLCs rather than C corporations, which ends the question before it starts, because QSBS requires C corporation stock.

Our position is that you should not pay for a structure, accept a lower price, or choose a C corporation holding company because of QSBS. If the holding company happens to be a C corporation and later guidance is favorable, that is a pleasant surprise. Planning around it is a mistake. The rollover equity page explains what you actually hold and how it is taxed at the second sale.

Does my state honor QSBS?

Even where the federal exclusion applies, the state answer varies.

California does not conform to Section 1202 at all. A California resident who sells QSBS with a full federal exclusion still owes California tax on the entire gain, at rates that reach 13.3 percent, because California taxes capital gain as ordinary income. California also does not conform to bonus depreciation and set its conformity date to January 1, 2025, deliberately leaving out the 2025 federal changes. The California page lists the other places where the state departs from federal law.

New York conforms today. The state starts from federal adjusted gross income, so a federal QSBS exclusion carries through to the state return. That could change. A bill to decouple from Section 1202, S8921, was introduced in January 2026 and withdrawn in March 2026. New York belongs on your watch list, especially if any of your rollover stock might qualify years from now. The New York page tracks this.

What is an Opportunity Zone and why does the calendar matter in 2026?

An Opportunity Zone is a low-income census tract designated under Section 1400Z-2, and a qualified opportunity fund (QOF) is an investment vehicle that puts money to work there. If you invest a capital gain into a QOF within 180 days of the sale, you defer the tax on that gain, and if you hold the QOF investment for 10 years, the gain on the fund itself is excluded.

The 2025 tax law made the program permanent. It also reset the map. New zone designations take effect January 1, 2027, and will be redrawn every 10 years after that. The important part for a 2026 seller is that the law created two sets of rules depending on when you invest, and 2026 falls on the wrong side of the line.

Read the first row again. A physician who closes a sale in June 2026 and invests the gain in a QOF in September 2026 defers the tax for about three months, then pays it on the 2026 return anyway, with no step-up. The only remaining benefit is the 10-year exclusion of the fund's growth, which is real but is not why most people invest.

Can a 2026 seller get the 2027 rules?

Often yes, because the 180-day investment window does not stop at year end. A gain recognized in the second half of 2026 has a 180-day window that runs into 2027. If you close on August 15, 2026, your window runs to roughly mid-February 2027. Investing in January 2027 rather than December 2026 puts you under the new rules: 5-year deferral, a 10 percent basis step-up at year 5, and the 10-year exclusion. The same gain, invested a few weeks later, gets a much better result.

Two cautions. The 180-day clock runs from the date the gain is recognized, which for a pass-through entity can be the entity's year end rather than the closing date, so confirm your start date with your CPA. And if your sale closes early in 2026, the window closes in 2026 and this option is not available; that is a reason to think about timing before you sign a closing date, not after.

Does my state conform to Opportunity Zones?

California does not. A California resident who defers federal tax through a QOF still owes California tax on the full gain in the year of sale. Since California taxes the gain at up to 13.3 percent, that is a large payment on money you have just locked up for 10 years. For a California seller the federal deferral has to be weighed against that state bill and the illiquidity together. Texas and Florida have no income tax, so the question does not arise. Confirm your own state's position before investing.

What are the risks of a QOF investment?

An opportunity fund is an investment first and a tax strategy second. Most funds hold real estate development or operating businesses in distressed areas, with a 10-year hold to get the full benefit. That means a decade with no easy way out, and the tax deferral is lost or reduced if you sell early. Fees can be high, both at the fund level and in the underlying projects, and they compound over 10 years. The fund must meet ongoing tests to keep its qualified status, and a fund that fails them can cost you the benefit through no fault of your own.

The right way to evaluate a QOF is to ask whether you would make this investment with no tax benefit at all. If the answer is no, the deferral does not change it. A 10 percent basis step-up on the deferred gain does not offset a fund that loses 30 percent of its value. We do not recommend or sell any fund, and we suggest treating any fund pitched primarily on the tax benefit with care.

Who should not use either of these tools?

• Any physician selling a practice, when it comes to QSBS. Section 1202(e)(3) closes the door. The only open question is rollover stock in an MSO holding company, and that is not a planning tool.
• A seller whose sale closes in the first half of 2026 and who wants an opportunity fund. The 180-day window ends inside 2026, so only the old rules apply.
• A California resident who is not prepared to pay state tax on the full gain in the sale year while the federal gain is deferred.
• Anyone who needs the sale proceeds to be liquid within the next 10 years, whether to fund retirement, pay for children's education, or replace the income that the scrape takes away.
• Anyone who has not done the simpler things first. Negotiating the purchase price allocation, checking your S election age, and funding a final-year retirement plan usually produce more tax saving with far less risk than a QOF.

What to do next

1. Stop the QSBS conversation early

   If an advisor or promoter raises QSBS on your practice sale, ask how the deal gets past Section 1202(e)(3). Move on when there is no answer. Ask your deal counsel whether the holding company is a C corporation or a partnership so you know whether the rollover question even applies.

2. Check your closing date against the 180-day window

   If you are interested in an opportunity fund and your sale will close in the second half of 2026, note that your window extends into 2027 and plan to invest after January 1, 2027. If your sale closes in the first half of 2026, an opportunity fund gets only the old rules.

3. Confirm your state's conformity

   California residents should assume no state benefit from either QSBS or opportunity zone deferral. New York residents should confirm the state has not moved on decoupling since March 2026.

4. Evaluate any fund as an investment

   Before committing, look at the fund's fees, its track record, its liquidity terms, and what happens if it loses qualified status. Decide whether you would own it with no tax benefit. The charitable strategies page covers other ways to reduce tax on a large gain that do not require a 10-year lockup.